The treatment of metabolic disease is becoming an increasingly important component of the
long-term management of patients with well controlled HIV on antiretroviral therapy (ART) …

HIV infection and antiretroviral therapy (ART) use are associated with perturbations in
glucose and lipid metabolism. Increasing incidence of diabetes, cardiovascular disease, and …

Background Metabolic diseases are frequently observed in HIV‐infected persons and, as
the risk of contracting these diseases is age‐related, their prevalence will increase in the …

The use of highly active antiretroviral therapy (HAART) in HIV-1 infection confers
immunological and survival advantages, at the cost of induction of significant metabolic …

The success of highly active antiretroviral therapy (HAART) has determined a dramatic
decline in AIDS-and immunodeficiency-related causes of death in the HIV-infected …

Increasingly effective therapies for HIV infection are now available. These treatments,
referred to collectively as highly active antiretroviral therapy, comprise various combinations …

Objective: Alterations in glucose and lipid metabolism, lactic acidemia, bone disorders, and
abnormal body fat distribution have been recognized recently as frequent complications …

Over the past 10 years, in conjunction with the broad availability of potent antiretroviral
regimens, the care of human immunodeficiency virus (HIV)–infected patients has shifted …

As result of the great benefit of HAART, AIDS-related deaths have dramatically declined
during the last decade in HIV-infected individuals. However, mortality due to non-AIDS …

In the absence of a cure, HIV-infected patients are being successfully treated with
antiretroviral therapies (ART) and living longer. Indeed, an increasing number of HIV …